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Among a wide variety of drug nanocarriers developed to date, liposome-based delivery systems are 
particularly attractive due to their advantageous features such as biocompatibility, complete 
biodegradability, low toxicity, ability to carry both hydrophilic and lipophilic payloads and protect them 
from chemical degradation and transformation, increased therapeutic index of a drug, improved 
pharmacokinetic and pharmacodynamic profiles compared to free drugs, reduced side effects, etc. The 
efficiency of drug encapsulation is largely determined by its membrane-partitioning properties as well as 
physicochemical characteristics of the lipid vesicles. In the present study we concentrated our efforts on 
the pre-formulation studies of the two synthesized Eu(III) coordination complexes, V3 and V4, the 
potential anticancer drugs. More specifically, our goal was twofold: i) to characterize the membrane 
partition properties of these complexes, and ii) to assess how the lipid-associating ability of V3 and V4 
depends on membrane structural state being varied by introducing the different amounts of cholesterol 
(Chol) into phosphatidylcholine (PC) lipid vesicles. To achieve this goal, several fluorescent probes 
including pyrene, 1,6-diphenyl-1,3,5-hexatriene (DPH), and 4-p-(dimethylaminostyryl)-1-
dodecylpyridinium (DSP-12) have been employed. Partition coefficients of lanthanides determined using 
the equilibrium dialysis technique proved to depend on the amount of Chol content. Formation of drug-
lipid complexes was found to affect pyrene excimerization and DSP-12 spectral properties but exerted no 
influence on pyrene vibronic structure and DPH anisotropy. Membrane composition was shown to have 
an impact on the spectral responses of the probes in drug-lipid systems. This finding was interpreted as 
arising from the sterol condensing effect on the structural state of the lipid bilayer.  
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Among a wide range of drug nanocarriers developed to date, liposome-based delivery 
systems are particularly attractive due to their following advantageous features. First, a 
variety of molecules could be encapsulated within the aqueous compartment of the liposomes 
as well as entrapped in the lipid bilayer [1]. Second, lipid vesicles can direct the drug to its 
specific target, protect the pharmacological compound against its degradation and chemical 
transformation, and prolong the duration of drug exposure. Finally, encapsulation of the 
compound into the lipid carriers allows reducing the adverse effects and controlling its 
movements in the human organism [1-3]. The efficiency of drug encapsulation is largely 
determined by its membrane-partitioning properties as well as physicochemical characteristics 
of the lipid vesicles. In the present study we concentrated our efforts on the pre-formulation 
studies of the two synthesized Eu(III) coordination complexes, V3 and V4, the potential 
anticancer drugs. More specifically, our goal was twofold: i) to characterize the membrane 
partition properties of these complexes, and ii) to assess how the lipid-associating ability of 
V3 and V4 depends on membrane structural state being varied by introducing the different 
amounts of cholesterol (Chol) into phosphatidylcholine (PC) lipid vesicles. To achieve this 
goal, several fluorescent probes including pyrene, 1,6-diphenyl-1,3,5-hexatriene (DPH), and 
4-p-(dimethylaminostyryl)-1-dodecylpyridinium (DSP-12) have been employed. 
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MATERIALS AND METHODS 
Egg yolk phosphatidylcholine was purchased from Biolek (Kharkov, Ukraine). DSP-12 
was obtained from Zonde (Latvia), pyrene, DPH and cholesterol (Chol) were from Sigma 
(Germany). Eu(III) coordination complexes (Fig. 1) were synthesized as described previously 
[4]. Lipid vesicles composed of PC and its mixtures with 5 (Chol5), 15 (Chol15) or 30 
(Chol30) mol% of Chol were prepared using the extrusion technique [5]. The thin lipid film 
was obtained by evaporation of lipids’ ethanol solutions and then hydrated with 1.2 ml of 5 
mM Na-phosphate buffer (pH 7.4). Lipid suspension was extruded through a 100 nm pore 
size polycarbonate filter. Phospholipid concentration was determined according to the 
procedure of Bartlett [6]. Absorption measurements were conducted using SF-46 
spectrophotometer. Fluorescence measurements were performed with CM 2203 
spectrofluorimeter equipped with magnetically stirred, thermostated cuvette holder (SOLAR, 
Belarus). 
 
RESULTS AND DISCUSSION 
At the first step of the study we evaluated 
the lipid association properties of compounds 
under study. Equilibrium dialysis was 
employed to quantify the drug partitioning into 
a lipid phase. In terms of this methodology the 
mole fraction partition coefficient is defined as 
[7]:  
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Fig. 1. Structure of europium coordination 
complexes. 
0
cA  and eqoutA  are the drug optical densit
 molar
ies at 266 nm in liposome-free and liposome-
containing systems, respectively, [ ]water  and [ ]lipid  represent water and lipid  
concentrations, respectively. Partition coefficients determined in such a way are presented in 
Table 1.  
 
Table 1. Partition coefficients of V3 and V4 in different lipid systems 
 PC Chol5 Chol15 Chol30 
V3 2.7×103 1.6×103 2.1×104 1×104
V4 3.2×104 n/d n/d n/d 
 
 * – not determined 
 
As seen from this table, partitioning of coordination complexes into the lipid phase is 
characterized by high values of PK suggesting the high efficiency of drug encapsulation into 
the liposomes. Notably, composition of the lipid vesicles strongly affects the partitioning of 
the lanthanides into the membranes. More specifically, Chol addition to PC bilayers resulted 
in the changing in PK  of V3 (Table 1). This finding can be interpreted as arising from the 
sterol condensing effect implicating the decreased free volume of lipid bilayer, augmented 
thickness of the membrane hydrocarbon region and increased number of PC molecules per 
unit area. Alterations in molecular volume occupied by PC are associated with the ordering of 
the lipid acyl chains and reduced rate of their trans-gauche isomerization due to specific 
orientation of the rigid sterol moiety. Within the framework of four-region model of lipid 
bilayer, Chol is suggested to localize in the Region 3 which involves polar/nonpolar interface 
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and initial parts of lipid tails. Since lanthanides are thought to reside at polar/nonpolar 
interface of the membrane [8-10], sterol-induced modifications in bilayer properties may 
result in the prevention of V3 partitioning into the liposomes.  
Next, it seems of interest to assess whether the high lipid binding ability of V3 and V4 is 
coupled with their influence on lipid bilayer physicochemical properties. To this end, a series 
of fluorescent probes including pyrene, DPH and DSP-12 has been employed. As seen in 
Table 2, the intensity ratio of the third to the first pyrene vibronic bands ( /III III IR I I= , where 
 and  – pyrene emission intensities at 374 and 384 nm, respectively), which is reported 
to be related to the alterations in membrane polarity, remains virtually unchanged upon V3 
and V4 association with all types of lipid vesicles under study. This finding suggests that the 
drugs do not affect the distribution of pyrene monomers and exert no influence on polarity of 
PC and PC:Chol lipid bilayers. In contrast, formation of drug-lipid complexes resulted in the 
changes in pyrene excimer-to-monomer intensity ratio (E/M), a parameter which reflects the 
rate of probe lateral diffusion within the membrane plane [11].  
II IIII
 
Table 2. Lanthanide effect on pyrene spectral parameters in PC and PC:Chol lipid vesicles 
Without V3 +V3 Without V4 +V4  
E/M IIIR  E/M IIIR  E/M IIIR  E/M IIIR  
PC 2.47 1.03 2.66 1.1 2.64 1.15 3.15 1.11 
Chol5 3.46 1.07 3.26 1.12 1.99 1.14 2.06 1.13 
Chol15 2.35 1.08 3.45 1.13 2.35 1.07 1.97 1.13 
Chol30 2.65 1.07 1.89 1.06 2.07 1.11 2.43 1.1 
 
Specifically, V3 and V4 encapsulation into PC liposomes led to the increase in E/M 
values (Table 2) being indicative of increased membrane free volume and decreased degree of 
lipid packing. Addition of Eu-complexes to PC:Chol vesicles resulted in ambiguous changes 
in E/M. V3 was found to reduce E/M in Chol5 and Chol30 membranes and increase E/M in 
Chol15 liposomes. V4 exhibited the opposite behavior – increased E/M ratio in the vesicles 
with low and high percentage of sterol, and decreased extent of pyrene excimerization in the 
vesicles containing 15 mol% of Chol. Apparently, the above effects may be explained by the 
balance of two competing processes – drug influence on bilayer structural state and modifying 
effect of Chol on membrane hydrophobic region 
[8]. A N
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In contrast to pyrene, DPH was found to be 
virtually insensitive to the lanthanide binding to 
the model lipid membranes – changes in probe 
anisotropy due to the drug encapsulation into the 
liposomes did not exceed 7%. The observed 
discrepancy in pyrene and DPH data may be 
explained by the difference in the mechanisms by 
which these probes respond to the alterations in 
their microenvironment. While the changes in 
pyrene excimerization arise from the 
modifications in probe lateral movements, 
variations in DPH anisotropy mirrors the changes 
in probe rotational mobility.  
Fig. 2. Structure (A) and deconvoluted 
fluorescence spectrum (B) of DSP-12. 
In order to get additional information on the 
molecular details of lanthanide association with 
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the model membranes, we examined the spectral behavior of DSP-12 in the drug-lipid 
systems. DSP-12 is a fluorescent probe possessing a charged hydrophilic fluorophore moiety 
(Fig. 2) and a long hydrophobic tail. The fluorescence spectrum of DSP-12 is characterized by 
two spectral components with the maxima at 567 and 619 nm attributing to the different probe 
populations – the former locating in the nonpolar membrane region, and the latter residing at 
the lipid/water interface. Incorporation of V3 and V4 into the liposomes exerted no influence 
on the contribution of long-wavelength component to the overall DSP-12 emission. 
Meantime, the relative intensity of the short-wavelength constituent of DSP-12 fluorescence 
was found to decrease by 13% in Chol5 liposomes and increase by 8% at higher Chol content. 
The fact that only the short-wavelength spectral component undergoes drug-induced changes 
strongly suggests that hydrophobic interactions play predominant role in lanthanide-
membrane association.  
Ambiguous dependence of the data presented here on Chol amount may be a 
cons
CONCLUSIONS 
The present study strongly suggest sized anticancer drugs V3 and V4 
can 
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